Metastatic breast cancer injection mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Neoplastic Cells, Circulating Tumor Cells, Cultured MCF-7 Cells Axilla Neoplastic Stem Cells Lymph Nodes Mammary Glands, Human Epithelial Cells

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases47

Breast Neoplasms Neoplasm Metastasis Carcinoma, Ductal, Breast Bone Neoplasms Disease Progression Neoplastic Cells, Circulating Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Breast Diseases Lymphatic Metastasis Carcinoma Lung Neoplasms Mammary Neoplasms, Experimental Neutropenia Neoplasm Recurrence, Local Neoplasms, Hormone-Dependent Liver Neoplasms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematologic Diseases Carcinoma, Intraductal, Noninfiltrating Carcinoma, Ductal Neoplasms Adenocarcinoma Inflammatory Breast Neoplasms Nausea Gastrointestinal Stromal Tumors Genetic Predisposition to Disease Alopecia Ovarian Neoplasms Soft Tissue Neoplasms Mammary Neoplasms, Animal Brain Neoplasms Fibrocystic Breast Disease Prostatic Neoplasms Fatigue Leukopenia Disease Models, Animal Peripheral Nervous System Diseases Colonic Neoplasms Thrombocytopenia Hand-Foot Syndrome Recurrence Neovascularization, Pathologic Vomiting Cell Transformation, Neoplastic Osteolysis

Chemicals and Drugs78

Receptor, erbB-2 Taxoids Paclitaxel Anthracyclines Antibodies, Monoclonal, Humanized Antineoplastic Agents Receptors, Estrogen Benzamides Tamoxifen Fluorouracil Bridged Compounds Cyclophosphamide Piperazines Epirubicin Deoxycytidine Pyrimidines Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Tumor Markers, Biological Receptors, Progesterone Doxorubicin Vinblastine Antibodies, Monoclonal Fluoxymesterone Thiotepa Aromatase Inhibitors Epothilones Antibiotics, Antineoplastic Nitriles Neoplasm Proteins Estrogen Antagonists Quinazolines Maytansine Mitolactol Triazoles Mucin-1 Antimetabolites, Antineoplastic Ketones Furans Mitoxantrone Fadrozole Megestrol Acetate Estrogen Receptor Modulators Aminoglutethimide Megestrol Protein Kinase Inhibitors Estrogens RNA, Messenger Estradiol Estrogen Receptor alpha Methotrexate Granulocyte Colony-Stimulating Factor Toremifene Selective Estrogen Receptor Modulators DNA, Neoplasm Antigens, Neoplasm Receptor, Epidermal Growth Factor RNA, Small Interfering Carboplatin BRCA2 Protein Pregnatrienes BRCA1 Protein Carcinoembryonic Antigen Cancer Vaccines Cisplatin Fusion Proteins, bcr-abl Diphosphonates Ki-67 Antigen Mammaglobin A Goserelin Enzyme Inhibitors Proto-Oncogene Proteins c-kit Antigens, Tumor-Associated, Carbohydrate Tumor Suppressor Protein p53 Prodrugs Leucovorin Angiogenesis Inhibitors MicroRNAs

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Drug Administration Schedule Disease-Free Survival Survival Analysis Prognosis Injections Survival Rate Neoplasm Staging Infusions, Intravenous Chemotherapy, Adjuvant Mammary Neoplasms, Experimental Combined Modality Therapy Kaplan-Meier Estimate Immunohistochemistry Retrospective Studies Mammography Mastectomy Clinical Trials as Topic Prospective Studies Administration, Oral Follow-Up Studies Clinical Trials, Phase III as Topic Risk Factors Reverse Transcriptase Polymerase Chain Reaction Salvage Therapy In Situ Hybridization, Fluorescence Gene Expression Profiling Early Detection of Cancer Neoplasm Transplantation Multivariate Analysis Injections, Intravenous Predictive Value of Tests Xenograft Model Antitumor Assays Case-Control Studies Sensitivity and Specificity Remission Induction Risk Assessment Tumor Burden Maximum Tolerated Dose Proportional Hazards Models Drug Evaluation Cohort Studies Blotting, Western Clinical Trials, Phase II as Topic Randomized Controlled Trials as Topic Transplantation, Heterologous Hematopoietic Stem Cell Transplantation Neoadjuvant Therapy Breast Self-Examination Molecular Targeted Therapy Feasibility Studies Risk Injections, Subcutaneous Confidence Intervals Transplantation, Autologous Oligonucleotide Array Sequence Analysis Pilot Projects Tissue Array Analysis Incidence Reproducibility of Results Transfection Immunoenzyme Techniques Odds Ratio Mastectomy, Segmental Logistic Models Palliative Care Disease Models, Animal Biopsy, Needle Drug Screening Assays, Antitumor Polymerase Chain Reaction Questionnaires Treatment Failure Injections, Intramuscular Double-Blind Method Registries Positron-Emission Tomography Drug Delivery Systems Probability Ultrasonography, Mammary Drug Approval

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes37

Drug Resistance, Neoplasm Genes, erbB-2 Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Postmenopause Time Factors Menopause Cell Proliferation Premenopause Genes, BRCA1 Sensitivity and Specificity Cell Movement Gene Amplification Signal Transduction Apoptosis Maximum Tolerated Dose Genetic Predisposition to Disease Breast Feeding Mutation Risk Cell Division Drug Synergism Genes, BRCA2 Transfection Up-Regulation Odds Ratio Down-Regulation Cell Survival Cell Growth Processes Gene Expression RNA Interference Phosphorylation Epithelial-Mesenchymal Transition Tumor Microenvironment Promoter Regions, Genetic Probability Osteolysis

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Survival Drug Approval

Humanities1

Quality of Life

Information Science4

Survival Rate Incidence Questionnaires Registries

Named Groups1

Health Care35

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Kaplan-Meier Estimate Retrospective Studies Clinical Trials as Topic Prospective Studies Follow-Up Studies Clinical Trials, Phase III as Topic Risk Factors Multivariate Analysis Predictive Value of Tests Case-Control Studies Sensitivity and Specificity Risk Assessment Proportional Hazards Models Cohort Studies Age Factors Clinical Trials, Phase II as Topic Randomized Controlled Trials as Topic Feasibility Studies Risk Confidence Intervals Pilot Projects Incidence Reproducibility of Results Odds Ratio Logistic Models Palliative Care Questionnaires Treatment Failure Double-Blind Method Registries Probability

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Neoplasms Neoplasm Metastasis Receptor, erbB-2 Breast Antineoplastic Combined Chemotherapy Protocols Taxoids Paclitaxel Anthracyclines Antibodies, Monoclonal, Humanized Antineoplastic Agents Treatment Outcome Drug Administration Schedule Receptors, Estrogen Disease-Free Survival Benzamides Carcinoma, Ductal, Breast Tamoxifen Fluorouracil Bone Neoplasms Bridged Compounds Cyclophosphamide Cell Line, Tumor Piperazines Epirubicin Deoxycytidine Survival Analysis Disease Progression Pyrimidines Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Tumor Markers, Biological Receptors, Progesterone Prognosis Neoplastic Cells, Circulating Drug Resistance, Neoplasm Doxorubicin Genes, erbB-2 Vinblastine Gene Expression Regulation, Neoplastic Antibodies, Monoclonal Fluoxymesterone Injections Neoplasm Invasiveness Breast Neoplasms, Male Thiotepa Survival Rate Neoplasm Staging Aromatase Inhibitors Epothilones Antibiotics, Antineoplastic Dose-Response Relationship, Drug Infusions, Intravenous Carcinoma, Lobular Chemotherapy, Adjuvant Postmenopause Breast Diseases Lymphatic Metastasis Carcinoma Time Factors Nitriles Lung Neoplasms Mammary Neoplasms, Experimental Neutropenia Neoplasm Proteins Combined Modality Therapy Kaplan-Meier Estimate Immunohistochemistry Retrospective Studies Estrogen Antagonists Quinazolines Mammography Neoplasm Recurrence, Local Mastectomy Clinical Trials as Topic Maytansine Mice, Nude Prospective Studies Mitolactol Administration, Oral Neoplasms, Hormone-Dependent Triazoles Mucin-1 Follow-Up Studies Antimetabolites, Antineoplastic Menopause Ketones Tumor Cells, Cultured Furans Clinical Trials, Phase III as Topic Mitoxantrone Fadrozole Risk Factors Cell Proliferation Megestrol Acetate Estrogen Receptor Modulators Reverse Transcriptase Polymerase Chain Reaction Aminoglutethimide Megestrol Premenopause Protein Kinase Inhibitors

No FAQ available that match "metastatic breast cancer injection mesylate"